Document is current
Any future updates will be listed below
-
Authors
Wu, Xin
Feng, Hao
Gao, Shujun
Feng, Hua
Diao, Wenjing
Zhang, Hongwei
Du, Ming
Lou, Weihua
Wang, Xipeng
Zhu, Tao
Zhang, Yuyang
Hu, Weiguo
Xue, Xiaohong
Zhu, Zhiling
Xiang, Libing
Li, Jiarui
Fang, Xuhong
Bai, Yongrui
Hou, Yanli
Yan, Weili
Qiu, Ling
Yu, Hailin
Zhu, Shurong
Du, Yan http://orcid.org/0000-0001-5413-7836
Jiang, Hua
-
Funding
Funding for this research was provided by:
Shanghai Hospital Development Center (SHDC2020CR1048B)
- License Information
-
More Information
Article History
Received: 20 January 2022
Accepted: 6 April 2022
First Online: 9 April 2022
Declarations
:
: Ethics approval has been obtained for the study protocol by the Institutional Review Board of the Obstetrics and Gynecology Hospital of Fudan University in Shanghai, China (Reference number: 2021–03; Date of approval: 18 January 2021). All patients will be given both written and oral information about the study from their gynecologist during the intake for surgery. Patients must sign an informed consent form in accordance with the Declaration of Helsinki before being included in the study. Refusal to participate will not affect standard treatment. Patients can withdraw from the study at any time during the study period. The patients or their family members can address their concerns or queries about the study related questions to the project leaders (HJ or XW) throughout the study period.
: Not applicable.
: There is no conflict of interest to disclose.
